|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
|
GB9823468D0
(en)
*
|
1998-10-28 |
1998-12-23 |
Secr Defence |
Novel enzyme
|
|
WO2001031028A2
(en)
*
|
1999-10-26 |
2001-05-03 |
The Secretary Of State For Defence |
Mutant luciferase
|
|
GB9925161D0
(en)
*
|
1999-10-26 |
1999-12-22 |
Secr Defence |
Novel enzyme
|
|
US7879540B1
(en)
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
|
US7083911B2
(en)
|
2001-02-16 |
2006-08-01 |
Promega Corporation |
Method for detection of ATP
|
|
GB0111275D0
(en)
|
2001-05-09 |
2001-06-27 |
Secr Defence |
Analytical method and kit
|
|
JP2006508339A
(ja)
|
2002-09-20 |
2006-03-09 |
プロメガ コーポレイション |
シトクロムp450活性を測定するための発光を利用する方法およびプローブ
|
|
EP2325328B1
(en)
|
2002-12-23 |
2014-02-12 |
Promega Corporation |
Improved luciferase-based assays
|
|
DE10315640A1
(de)
*
|
2003-04-04 |
2004-10-14 |
Ignatov, Konstantin |
Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
|
|
EP1687399A4
(en)
*
|
2003-10-03 |
2007-09-05 |
Univ Michigan Tech |
MODIFIED LUCIFERASE
|
|
US8183036B2
(en)
|
2003-10-10 |
2012-05-22 |
Promega Corporation |
Luciferase biosensor
|
|
BR122018071808B8
(pt)
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
|
BRPI0510883B8
(pt)
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
|
|
CN101040054A
(zh)
*
|
2004-07-02 |
2007-09-19 |
普罗美加公司 |
微生物atp提取及检测系统
|
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
|
CN101065151B
(zh)
|
2004-09-23 |
2014-12-10 |
健泰科生物技术公司 |
半胱氨酸改造的抗体和偶联物
|
|
EP1817336B1
(en)
|
2004-11-12 |
2019-01-09 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
EP2778234B1
(en)
|
2005-05-31 |
2017-09-27 |
Promega Corporation |
Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
|
|
EP1935986B1
(en)
|
2005-05-31 |
2014-04-16 |
Promega Corporation |
Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
|
|
GB0513535D0
(en)
*
|
2005-07-01 |
2005-08-10 |
Iseao Technologies Ltd |
Improved methods of detecting microbes
|
|
ES2585357T3
(es)
|
2005-07-07 |
2016-10-05 |
Seattle Genetics, Inc. |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
GB0516455D0
(en)
*
|
2005-08-10 |
2005-09-14 |
Lumora Ltd |
pH tolerant luciferase
|
|
GB0517005D0
(en)
|
2005-08-19 |
2005-09-28 |
Enigma Diagnostics Ltd |
Analytical method and kit
|
|
EP2327768B1
(en)
*
|
2006-04-03 |
2015-09-09 |
Promega Corporation |
Permuted and nonpermuted luciferase biosensors
|
|
HRP20140172T1
(hr)
|
2006-05-30 |
2014-03-28 |
Genentech, Inc. |
Protutijela i imunokonjugati kao i njihove uporabe
|
|
US20100008910A1
(en)
|
2006-09-12 |
2010-01-14 |
John Chant |
Methods and compositions for the diagnosis and treatment of cancer
|
|
CA2667019C
(en)
|
2006-10-27 |
2016-03-29 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
TWI499420B
(zh)
|
2006-12-07 |
2015-09-11 |
Hoffmann La Roche |
肌醇磷脂3-激酶抑制劑化合物及使用方法
|
|
EP2641618A3
(en)
|
2007-07-16 |
2013-10-23 |
Genentech, Inc. |
Humanized anti-CD79B antibodies and immunoconjugates and methods of use
|
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
|
CA2704711C
(en)
|
2007-09-24 |
2016-07-05 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
CN104650230A
(zh)
|
2008-01-31 |
2015-05-27 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
|
CA2718942A1
(en)
|
2008-03-18 |
2009-09-24 |
Seattle Genetics, Inc. |
Auristatin drug linker conjugates
|
|
MY166445A
(en)
|
2008-03-18 |
2018-06-27 |
Genentech Inc |
Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents,and methods of use
|
|
WO2009140662A1
(en)
*
|
2008-05-15 |
2009-11-19 |
Illumina, Inc. |
Engineered luciferases
|
|
JP6110591B2
(ja)
|
2008-05-19 |
2017-04-05 |
プロメガ コーポレイションPromega Corporation |
cAMPのためのルシフェラーゼバイオセンサー
|
|
US7852663B2
(en)
|
2008-05-23 |
2010-12-14 |
Seagate Technology Llc |
Nonvolatile programmable logic gates and adders
|
|
JP2010004758A
(ja)
*
|
2008-06-24 |
2010-01-14 |
Probex Inc |
cyclicGMP検出方法
|
|
AR072804A1
(es)
|
2008-07-15 |
2010-09-22 |
Genentech Inc |
Conjugados derivados de antraciclina,proceso para su preparacion,composiciones farmaceuticas que los contienen y su uso como agentes antitumorales.
|
|
CN102159948B
(zh)
|
2008-07-22 |
2014-06-25 |
普罗美加公司 |
基于adp检测的发光磷酸转移酶或atp水解酶测定
|
|
US8288559B2
(en)
|
2008-08-18 |
2012-10-16 |
Promega Corporation |
Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
|
|
US7985994B2
(en)
|
2008-09-29 |
2011-07-26 |
Seagate Technology Llc |
Flux-closed STRAM with electronically reflective insulative spacer
|
|
US8089132B2
(en)
|
2008-10-09 |
2012-01-03 |
Seagate Technology Llc |
Magnetic memory with phonon glass electron crystal material
|
|
US8045366B2
(en)
|
2008-11-05 |
2011-10-25 |
Seagate Technology Llc |
STRAM with composite free magnetic element
|
|
US8289756B2
(en)
|
2008-11-25 |
2012-10-16 |
Seagate Technology Llc |
Non volatile memory including stabilizing structures
|
|
US7826259B2
(en)
|
2009-01-29 |
2010-11-02 |
Seagate Technology Llc |
Staggered STRAM cell
|
|
UA103918C2
(en)
|
2009-03-02 |
2013-12-10 |
Айерем Элелси |
N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
|
|
AU2010224125B2
(en)
|
2009-03-12 |
2015-05-14 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
EP2414399A1
(en)
|
2009-04-01 |
2012-02-08 |
F. Hoffmann-La Roche AG |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
|
KR101962476B1
(ko)
|
2009-07-03 |
2019-03-26 |
아비펩 피티와이 리미티트 |
면역성 접합체 및 그 제조방법
|
|
US8102703B2
(en)
*
|
2009-07-14 |
2012-01-24 |
Crocus Technology |
Magnetic element with a fast spin transfer torque writing procedure
|
|
SG10201405568UA
(en)
|
2009-09-08 |
2014-11-27 |
Hoffmann La Roche |
4-substituted pyridin-3-yl-carboxamide compounds and methods of use
|
|
WO2011036280A1
(en)
|
2009-09-28 |
2011-03-31 |
F. Hoffmann-La Roche Ag |
Benzoxazepin pi3k inhibitor compounds and methods of use
|
|
RU2557658C2
(ru)
|
2009-09-28 |
2015-07-27 |
Ф.Хоффманн-Ля Рош Аг |
Бензоксепиновые ингибиторы pi3 и способы применения
|
|
CN102770456B
(zh)
|
2009-12-04 |
2018-04-06 |
弗·哈夫曼-拉罗切有限公司 |
多特异性抗体、抗体类似物、组合物和方法
|
|
US9315581B2
(en)
|
2009-12-23 |
2016-04-19 |
A Vipep Pty Limited |
Immuno-conjugates and methods for producing them
|
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
|
BR112012026213B1
(pt)
|
2010-04-15 |
2021-12-28 |
Medimmune Limited |
Compostos de pirrolobenzodiazepinas, conjugado das mesmas, composição farmacêutica compreendendo o conjugado e uso do mesmo para o tratamento de uma doença proliferativa
|
|
US9290794B2
(en)
|
2010-05-11 |
2016-03-22 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
EP2990479B1
(en)
*
|
2010-05-11 |
2019-03-27 |
Promega Corporation |
Mutant protease biosensors with enhanced detection characteristics
|
|
CN103119442A
(zh)
|
2010-06-03 |
2013-05-22 |
霍夫曼-拉罗奇有限公司 |
抗体和免疫偶联物的免疫peg成像及其用途
|
|
WO2011156328A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
KR101885388B1
(ko)
|
2010-06-18 |
2018-08-03 |
제넨테크, 인크. |
항-Axl 항체 및 사용 방법
|
|
UY33469A
(es)
|
2010-06-29 |
2012-01-31 |
Irm Llc Y Novartis Ag |
Composiciones y metodos para modular la via de señalizacion de wnt
|
|
SG10202103336SA
(en)
|
2010-11-02 |
2021-04-29 |
Promega Corp |
Novel coelenterazine substrates and methods of use
|
|
DK2635583T3
(en)
|
2010-11-02 |
2015-08-03 |
Promega Corp |
Coelenterazinderivater and methods of use thereof
|
|
CN103313990B
(zh)
|
2010-11-17 |
2016-07-20 |
基因泰克公司 |
丙氨酰美登醇抗体偶联物
|
|
MX2013006858A
(es)
|
2010-12-16 |
2013-07-29 |
Hoffmann La Roche |
Compuesto triciclicos inhibidores de la pi3k y metodos de uso.
|
|
NZ610976A
(en)
|
2010-12-20 |
2015-07-31 |
Genentech Inc |
Anti-mesothelin antibodies and immunoconjugates
|
|
AU2012236511B2
(en)
|
2011-03-30 |
2016-04-28 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State University |
Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
|
|
SG10201504303SA
(en)
|
2011-04-01 |
2015-07-30 |
Genentech Inc |
Combinations Of AKT Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
|
|
TR201815685T4
(tr)
|
2011-04-01 |
2018-11-21 |
Genentech Inc |
Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
|
|
MX342240B
(es)
|
2011-04-07 |
2016-09-21 |
Genentech Inc |
Anticuerpos anti-fgfr4 y metodos de uso.
|
|
PT2710018T
(pt)
|
2011-05-19 |
2022-03-01 |
Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio |
Compostos macrocíclicos como inibidores de proteína quinases
|
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
|
US20140363438A1
(en)
|
2011-08-17 |
2014-12-11 |
Genentech, Inc. |
Neuregulin antibodies and uses thereof
|
|
SG11201401406YA
(en)
|
2011-10-14 |
2014-05-29 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
KR101696525B1
(ko)
|
2011-11-03 |
2017-01-13 |
에프. 호프만-라 로슈 아게 |
Btk 활성 억제제로서의 8-플루오로프탈라진-1(2h)-온 화합물
|
|
KR101716011B1
(ko)
|
2011-11-03 |
2017-03-13 |
에프. 호프만-라 로슈 아게 |
Btk 활성의 억제제인 알킬화된 피페라진 화합물
|
|
KR20140096100A
(ko)
|
2011-11-03 |
2014-08-04 |
에프. 호프만-라 로슈 아게 |
이환 피페라진 화합물
|
|
UA111756C2
(uk)
|
2011-11-03 |
2016-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
|
|
WO2013070894A1
(en)
|
2011-11-08 |
2013-05-16 |
The Procter & Gamble Company |
Method of identifying prebiotics and compositions containing the same
|
|
JP6421977B2
(ja)
*
|
2011-11-11 |
2018-11-14 |
プロメガ コーポレイションPromega Corporation |
検出特性を向上させた変異プロテアーゼバイオセンサー
|
|
BR112014012590A8
(pt)
|
2011-11-23 |
2017-12-19 |
Igenica Inc |
Anticorpos anti-cd98 e métodos de uso dos mesmos
|
|
AR090549A1
(es)
|
2012-03-30 |
2014-11-19 |
Genentech Inc |
Anticuerpos anti-lgr5 e inmunoconjugados
|
|
US9056910B2
(en)
|
2012-05-01 |
2015-06-16 |
Genentech, Inc. |
Anti-PMEL17 antibodies and immunoconjugates
|
|
CN104520291A
(zh)
|
2012-06-06 |
2015-04-15 |
Irm责任有限公司 |
用于调节egfr活性的化合物和组合物
|
|
JO3300B1
(ar)
|
2012-06-06 |
2018-09-16 |
Novartis Ag |
مركبات وتركيبات لتعديل نشاط egfr
|
|
SG10201706196XA
(en)
|
2012-06-08 |
2017-08-30 |
Hoffmann La Roche |
Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
|
KR20150030698A
(ko)
|
2012-07-09 |
2015-03-20 |
제넨테크, 인크. |
항-cd79b 항체를 포함하는 면역접합체
|
|
AU2013288930A1
(en)
|
2012-07-09 |
2014-12-04 |
Genentech, Inc. |
Immunoconjugates comprising anti-CD79b antibodies
|
|
SG11201500087VA
(en)
|
2012-07-09 |
2015-02-27 |
Genentech Inc |
Immunoconjugates comprising anti-cd22 antibodies
|
|
AR091701A1
(es)
|
2012-07-09 |
2015-02-25 |
Genentech Inc |
Anticuerpos anti-cd22 e inmunoconjugados
|
|
BR112015002493A8
(pt)
|
2012-08-30 |
2019-07-30 |
Hoffmann La Roche |
composto, composição farmacêutica, processo para a preparação de uma composição farmacêutica, kit e uso de um composto”
|
|
US20150231240A1
(en)
|
2012-10-09 |
2015-08-20 |
Igenica Biotherapeutics, Inc. |
Anti-c16orf54 antibodies and methods of use thereof
|
|
ES2713164T3
(es)
|
2012-10-12 |
2019-05-20 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
SI2906253T1
(sl)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin-protitelo proti PSMA
|
|
WO2014057122A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
EP2906250B1
(en)
|
2012-10-12 |
2018-05-30 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
US10695433B2
(en)
|
2012-10-12 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2014057074A1
(en)
|
2012-10-12 |
2014-04-17 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
SMT201800346T1
(it)
|
2012-10-12 |
2018-09-13 |
Medimmune Ltd |
Coniugati pirrolobenzodiazepina-anticorpo
|
|
PT2906298T
(pt)
|
2012-10-12 |
2018-12-28 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepina-anticorpos
|
|
JP6307519B2
(ja)
|
2012-12-21 |
2018-04-04 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピンおよびその結合体
|
|
CN110627797A
(zh)
|
2012-12-21 |
2019-12-31 |
麦迪穆有限责任公司 |
用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
|
|
EP4306649A3
(en)
|
2013-02-22 |
2024-04-03 |
Promega Corporation |
Stabilized formulation for luminescent detection of luciferase and nucleoside phosphates
|
|
KR102182488B1
(ko)
|
2013-02-25 |
2020-11-24 |
제넨테크, 인크. |
약물 내성 akt 돌연변이체의 검출 및 치료를 위한 방법 및 조성물
|
|
AU2014230735B2
(en)
|
2013-03-13 |
2018-03-15 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP2968596B1
(en)
|
2013-03-13 |
2019-03-06 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
JP6340019B2
(ja)
|
2013-03-13 |
2018-06-06 |
メドイミューン・リミテッドMedImmune Limited |
ピロロベンゾジアゼピン及びそのコンジュゲート
|
|
WO2014159835A1
(en)
|
2013-03-14 |
2014-10-02 |
Genentech, Inc. |
Anti-b7-h4 antibodies and immunoconjugates
|
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
|
HK1211963A1
(en)
|
2013-03-15 |
2016-06-03 |
豪夫迈.罗氏有限公司 |
Compositions and methods for diagnosis and treatment of hepatic cancers
|
|
RU2016101548A
(ru)
|
2013-07-03 |
2017-08-08 |
Ф. Хоффманн-Ля Рош Аг |
Соединения амидов гетероарилпиридона и азапиридона
|
|
US10442836B2
(en)
|
2013-08-12 |
2019-10-15 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
AR097685A1
(es)
|
2013-09-17 |
2016-04-06 |
Genentech Inc |
Métodos de uso de anticuerpos anti-lgr5
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015083059A1
(en)
|
2013-12-02 |
2015-06-11 |
Novartis Ag |
Forms of the egfr inhibitor
|
|
RU2646758C2
(ru)
|
2013-12-05 |
2018-03-07 |
Ф. Хоффманн-Ля Рош Аг |
Гетероарил пиридоны и азапиридоны с электрофильной функциональностью
|
|
AU2014362238A1
(en)
|
2013-12-13 |
2016-06-09 |
Genentech, Inc. |
Anti-CD33 antibodies and immunoconjugates
|
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック, インコーポレイテッド |
1−(クロロメチル)−2,3−ジヒドロ−1h−ベンゾ[e]インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
EP3096797A1
(en)
|
2014-01-24 |
2016-11-30 |
F. Hoffmann-La Roche AG |
Methods of using anti-steap1 antibodies and immunoconjugates
|
|
JP6588917B2
(ja)
|
2014-01-29 |
2019-10-09 |
プロメガ コーポレイションPromega Corporation |
生細胞への適用のためのプロ基質
|
|
WO2015116867A1
(en)
|
2014-01-29 |
2015-08-06 |
Promega Corporation |
Quinone-masked probes as labeling reagents for cell uptake measurements
|
|
SG11201607334YA
(en)
|
2014-03-13 |
2016-10-28 |
Hoffmann La Roche |
Therapeutic combinations with estrogen receptor modulators
|
|
GB201406767D0
(en)
|
2014-04-15 |
2014-05-28 |
Cancer Rec Tech Ltd |
Humanized anti-Tn-MUC1 antibodies anf their conjugates
|
|
BR112016027222A2
(pt)
|
2014-05-22 |
2018-01-30 |
Genentech Inc |
anticorpos isolados, ácido nucleico isolado, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de tratamento de um indivíduo com um câncer, de inibição da proliferação de uma célula, de detecção de gpc3 humano e de detecção de um câncer
|
|
KR20170010785A
(ko)
|
2014-06-11 |
2017-02-01 |
제넨테크, 인크. |
항-lgr5 항체 및 이의 용도
|
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2016040788A1
(en)
|
2014-09-11 |
2016-03-17 |
Promega Corporation |
Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence
|
|
PE20170935A1
(es)
|
2014-09-12 |
2017-07-13 |
Genentech Inc |
Anticuerpos anti-her2 e inmunoconjugados
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
CR20170095A
(es)
|
2014-09-12 |
2017-07-19 |
Genentech Inc |
Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas
|
|
MX2017003123A
(es)
|
2014-09-12 |
2017-05-12 |
Genentech Inc |
Anticuerpos y conjugados modificados geneticamente con cisteina.
|
|
JP6622293B2
(ja)
|
2014-09-12 |
2019-12-18 |
ジェネンテック, インコーポレイテッド |
アントラサイクリンジスルフィド中間体、抗体−薬物複合体、及び方法
|
|
KR20170055521A
(ko)
|
2014-09-17 |
2017-05-19 |
제넨테크, 인크. |
항-her2 항체를 포함하는 면역콘주게이트
|
|
AU2015317653A1
(en)
|
2014-09-17 |
2017-04-06 |
Genentech, Inc. |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof
|
|
JP6507234B2
(ja)
|
2014-10-02 |
2019-04-24 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
ブルトンチロシンキナーゼ(btk)によって介入される障害の処置における使用のためのピラゾールカルボキサミド化合物
|
|
JP6510041B2
(ja)
|
2014-10-08 |
2019-05-08 |
プロメガ コーポレイションPromega Corporation |
生物発光サクシネート検出アッセイ
|
|
US10780096B2
(en)
|
2014-11-25 |
2020-09-22 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US10206942B2
(en)
|
2015-04-10 |
2019-02-19 |
Thomas Jefferson University |
Methods and compositions for treating cancers and enhancing therapeutic immunity by selectively reducing immunomodulatory M2 monocytes
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506389D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
EP3307780A1
(en)
|
2015-06-15 |
2018-04-18 |
Genentech, Inc. |
Antibodies and immunoconjugates
|
|
CN107847568B
(zh)
|
2015-06-16 |
2022-12-20 |
豪夫迈·罗氏有限公司 |
抗cll-1抗体和使用方法
|
|
AU2016313263B2
(en)
|
2015-08-26 |
2021-02-04 |
Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Condensed tricyclic compounds as protein kinase inhibitors
|
|
MA43345A
(fr)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
Conjugués anticorps-médicaments de pyrrolobenzodiazépine et méthodes d'utilisation
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
|
JP6493316B2
(ja)
*
|
2016-06-21 |
2019-04-03 |
東亜ディーケーケー株式会社 |
変異型甲虫ルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型甲虫ルシフェラーゼの製造方法
|
|
WO2018031662A1
(en)
|
2016-08-11 |
2018-02-15 |
Genentech, Inc. |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
|
EP3516068B1
(en)
*
|
2016-09-19 |
2025-04-23 |
University of Southern California |
Non-radioactive cytotoxicity assays
|
|
EP3526343B1
(en)
*
|
2016-10-13 |
2025-04-16 |
Promega Corporation |
Thermal stable luciferase with improved resistance to inhibition by luciferin break-down products
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
WO2018091724A1
(en)
|
2016-11-21 |
2018-05-24 |
Cureab Gmbh |
Anti-gp73 antibodies and immunoconjugates
|
|
ES2871001T3
(es)
|
2017-02-08 |
2021-10-28 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepinas y anticuerpos
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
PL3579883T3
(pl)
|
2017-02-08 |
2022-01-24 |
Adc Therapeutics Sa |
Koniugaty pirolobenzodiazepina-przeciwciało
|
|
WO2018192944A1
(en)
|
2017-04-18 |
2018-10-25 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
CA3057748A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
ES2988683T3
(es)
|
2017-06-14 |
2024-11-21 |
Adc Therapeutics Sa |
Pautas posológicas para la administración de un CAF anti-CD19
|
|
EP3661932B1
(en)
|
2017-08-04 |
2021-10-06 |
Promega Corporation |
Compositions and methods for stabilizing benzothiazole luciferin analogs
|
|
SG11202000358YA
(en)
|
2017-08-18 |
2020-02-27 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
KR20220156974A
(ko)
|
2017-09-20 |
2022-11-28 |
주식회사 피에이치파마 |
타일란스타틴 유사체
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
US11767517B2
(en)
*
|
2018-06-05 |
2023-09-26 |
Promega Corporation |
Luciferase enzymes for use with thermostable luciferins in bioluminescent assays
|
|
MX2021010477A
(es)
|
2019-03-15 |
2021-10-01 |
Medimmune Ltd |
Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
|
|
GB201908128D0
(en)
|
2019-06-07 |
2019-07-24 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
UA128549C2
(uk)
|
2019-12-27 |
2024-08-07 |
Чугаі Сейяку Кабусікі Кайся |
Антитіло до ctla-4 та його застосування
|
|
EP4146283A1
(en)
|
2020-05-03 |
2023-03-15 |
Levena (Suzhou) Biopharma Co., Ltd. |
Antibody-drug conjugates (adcs) comprising an anti-trop-2 antibody, compositions comprising such adcs, as well as methods of making and using the same
|
|
WO2021231400A1
(en)
|
2020-05-12 |
2021-11-18 |
Accutar Biotechnology, Inc. |
Bis-aryl ethers containing n-acyl azetidine as egfr/her2 inhibitors
|
|
WO2022147532A1
(en)
|
2021-01-04 |
2022-07-07 |
Mersana Therapeutics, Inc. |
B7h4-targeted antibody-drug conjugates and methods of use thereof
|
|
CA3210069A1
(en)
|
2021-03-03 |
2022-09-09 |
Tong Zhu |
Antibody-drug conjugates comprising an anti-bcma antibody
|
|
EP4333822A1
(en)
|
2021-05-03 |
2024-03-13 |
Lead Discovery Center GmbH |
Composition comprising an inhibitor of mitochondrial transcription
|
|
JP7472405B2
(ja)
|
2021-06-25 |
2024-04-22 |
中外製薬株式会社 |
抗ctla-4抗体
|
|
TWI864408B
(zh)
|
2021-06-25 |
2024-12-01 |
日商中外製藥股份有限公司 |
抗ctla-4抗體的用途
|
|
CA3245693A1
(en)
|
2022-03-10 |
2023-09-14 |
Vivasor, Inc. |
ANTIBODY-DRUG CONJUGATIONS AND THEIR USES
|
|
KR20250006932A
(ko)
|
2022-05-03 |
2025-01-13 |
제넨테크, 인크. |
항-Ly6E 항체, 면역접합체 및 이들의 용도
|
|
WO2024044550A1
(en)
|
2022-08-22 |
2024-02-29 |
Abdera Therapeutics Inc. |
Dll3 binding molecules and uses thereof
|
|
EP4637833A2
(en)
|
2022-12-23 |
2025-10-29 |
Genentech, Inc. |
Cereblon degrader conjugates, and uses thereof
|
|
WO2024153750A1
(en)
*
|
2023-01-18 |
2024-07-25 |
Enzyre B.V. |
Luminescent detection of adamts13
|
|
CN120457210A
(zh)
|
2023-01-27 |
2025-08-08 |
龟甲万株式会社 |
萤光素酶突变体
|
|
WO2024211234A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211235A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211236A2
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024259216A1
(en)
|
2023-06-16 |
2024-12-19 |
Accutar Biotechnology, Inc. |
Quinoxaline derived sulfonamides with egfr degradation activities and their uses thereof
|
|
CN117925547B
(zh)
*
|
2023-08-01 |
2024-10-11 |
上海碧云天生物技术股份有限公司 |
经改造的萤火虫萤光素酶、其制备方法及应用
|